Antimicrobial Characterization of Human β-Defensin 3 Derivatives
- 1 September 2003
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 47 (9) , 2804-2809
- https://doi.org/10.1128/aac.47.9.2804-2809.2003
Abstract
Human β-defensin 3 (hBD3) is a highly basic 45-amino-acid protein that acts both as an antimicrobial agent and as a chemoattractant molecule. Although the nature of its antimicrobial activity is largely electrostatic, the importance of the molecular structure on this activity is poorly understood. Two isoforms of hBD3 were synthesized: the first with native disulfide linkages and the second with nonnative linkages. In a third synthetic peptide, all cysteine residues were replaced with α-aminobutyric acid, creating a completely linear peptide. A series of six small, linear peptides corresponding to regions of hBD3 with net charges ranging from +4 to +8 (at pH 7) and lengths ranging from 9 to 20 amino acids were also synthesized. The linear full-length peptide showed the highest microbicidal activity againstEscherichia coliandStaphylococcus aureus, while all three full-length forms showed equal activity againstCandida albicans. The linear peptide also showed high activity againstEnterococcus faeciumandPseudomonas aeruginosa.Peptides corresponding to the C terminus showed higher activities when tested againstE. coli, with the most active peptides being the most basic. However, only the peptide corresponding to the N terminus of hBD3 showed any activity againstS. aureusandC. albicans. Further, N-terminal deletion mutants of native hBD3 showed diminished activities againstS. aureus. Thus, the antimicrobial properties of hBD3 derivatives are determined by both charge and structure.Keywords
This publication has 41 references indexed in Scilit:
- Susceptibility of Nontypeable Haemophilus influenzae to Human β-Defensins Is Influenced by Lipooligosaccharide AcylationInfection and Immunity, 2002
- Identification of a novel, multifunctional *-defensin (human *-defensin 3) with specific antimicrobial activityCell and tissue research, 2001
- Human β‐defensin 4: a novel inducible peptide with a specific salt‐sensitive spectrum of antimicrobial activityThe FASEB Journal, 2001
- Isolation and Characterization of Human μ-Defensin-3, a Novel Human Inducible Peptide AntibioticJournal of Biological Chemistry, 2001
- Discovery of new human β-defensins using a genomics-based approachGene, 2001
- hBD‐1: a novel β‐defensin from human plasmaPublished by Wiley ,2000
- Specific Binding Sites for an Antifungal Plant Defensin from Dahlia (Dahlia merckii) on Fungal Cells Are Required for Antifungal ActivityMolecular Plant-Microbe Interactions®, 2000
- Epithelial Defensins Impair Adenoviral Infection: Implication for Adenovirus-Mediated Gene TherapyHuman Gene Therapy, 1999
- In situ neutralization in Boc‐chemistry solid phase peptide synthesisInternational Journal of Peptide and Protein Research, 1992
- Human neutrophil peptide defensins induce single strand DNA breaks in target cellsCellular Immunology, 1991